Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212). Panitumumab ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are commonly used for the minimally invasive treatment of submucosal lesions of the gastrointestinal tract. To evaluate ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Although endoscopic submucosal dissection continues to gain ground in managing colorectal laterally ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

DELRAY BEACH, Fla., Aug. 27, 2025 /PRNewswire/ -- The global Endoscopic Submucosal Dissection Market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at ...

We identified appropriate articles by an electronic search of MEDLINE for the reports published between January 1980 and June 2012 using "endoscopic submucosal dissection," "endoscopic mucosal ...

Endoscopic submucosal dissection (ESD) is a safe and very effective alternative to surgery for the treatment of colorectal tumors, reports a new study from Japan. Surgery has been the only available ...